A U.S. federal appeals court on Wednesday
upheld a ruling that Biogen Inc's patents on its blockbuster
multiple sclerosis drug Tecfidera are valid, rejecting a
challenge by Danish drugmaker Forward Pharma A/S.
Talks between BlackRock
and Intesa Sanpaolo over an asset management tie-up
have slowed due to political uncertainty, but the deal is not
yet off, two sources familiar with the matter said on Wednesday.
The sharp surge in Tesla Inc's
share price on Tuesday slammed short sellers of the stock with
$1.11 billion in losses for the day on paper, pushing their
performance for the year into the red, according to financial
analytics firm S3 Partners.